STRO vs STX · rev $62.0M vs P/E 101, rev $9.10B
Sutro Biopharma (STRO) versus Seagate Technology PLC (STX) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Seagate Technology PLC (STX) is a computer hardware company listed on NASDAQ.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported STX revenue for 2025-06-27 was $9.10B. Net income was $1.47B. STX currently screens at market cap $241.20B and trailing P/E 101.3.
STRO currently screens at market cap $470.8M. STX currently screens at market cap $241.20B and trailing P/E 101.3.
Not investment advice. Open the STRO and STX stock pages for the full models.
Not investment advice.